Adverse reactions to β-lactam antimicrobials

Expert Opinion on Drug Safety

Volumn 11, Issue 3, 2012, Pages 381-399

  Lagacé Wiens, Philippe ^a,b   Rubinstein, Ethan ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adverse event; Allergy; Antibiotic; Antimicrobial; Beta lactam; Carbapenem; Cephalosporin; Crossreactivity; Drug related; Hypersensitivity; Penicillin; Rash; Review; Side effect

Indexed keywords

AMOXICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFACLOR; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFAPIRIN; CEFATRIZINE; CEFAZOLIN; CEFEPIME; CEFETAMET; CEFMETAZOLE; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFRADINE; CEFTAZIDIME; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; PENICILLIN G; PIPERACILLIN; UNINDEXED DRUG;

ABDOMINAL PAIN; ACUTE HEPATITIS; AGRANULOCYTOSIS; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTHRITIS; ATAXIA; BRONCHOSPASM; CANDIDIASIS; CHOLESTATIC HEPATITIS; CLOSTRIDIUM DIFFICILE INFECTION; CONTACT DERMATITIS; CROSS ALLERGY; CROSS REACTION; DESENSITIZATION; DIARRHEA; DIPLOPIA; DISORIENTATION; DRESS SYNDROME; DRUG BIOAVAILABILITY; DRUG ERUPTION; DRUG SAFETY; EOSINOPHILIA; ERYTHEMA MULTIFORME; FEVER; GLOMERULONEPHRITIS; GRAND MAL SEIZURE; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; INTRACRANIAL HYPERTENSION; INTRACUTANEOUS TEST; LARYNX EDEMA; LEUKOPENIA; LIVER TOXICITY; LUNG INFILTRATE; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALAISE; MENINGITIS; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PATCH TEST; PENICILLIN ALLERGY; PHARMACODYNAMICS; PRURITUS; PUSTULOSIS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SERUM SICKNESS; SKIN TEST; SMALL VESSEL VASCULITIS; STEVENS JOHNSON SYNDROME; STRUCTURE ACTIVITY RELATION; SWELLING; THROMBOCYTOPATHY; THROMBOCYTOPENIA; TINNITUS; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS; VERTIGO; VOMITING; WHEEZING;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DIGESTIVE SYSTEM DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; HEMATOLOGIC DISEASES; HUMANS; KIDNEY DISEASES; MOLECULAR STRUCTURE; NERVOUS SYSTEM DISEASES; RISK ASSESSMENT; RISK FACTORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84860163165     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2012.643866     Document Type: Review

References (152)

1. Smith RG. Penicillin and cephalosporin drug allergies: a paradigm shift. J Am Podiatr Med Assoc 2008;98:479-88
2. Cunha BA. Antibiotic side effects. Med Clin North Am 2001;85:149-85 (Pubitemid 32038727)
3. Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis 2007;57:13S-8S
4. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 2007;136:340-7
5. Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract 2006;55:106-12
6. Blondeau JM. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? J Antimicrob Chemother 2009;63:238-42
7. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 2008;121:572-6 (Pubitemid 351876171)
8. DePestel DD, Benninger MS, Danziger L, et al. Cephalosporin use in treatment of patients with penicillin allergies (2003). J Am Pharm Assoc 2008;48:530-40
9. Baldo BA, Pham NH, Zhao Z. Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol 2001;1:327-35
10. Andes DR, Craig WA. Cephalosporins. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. Elsevier; Philadelphia, PA: 2009. p. 323-39
11. Moreno E, Macias E, Davila I, et al. Hypersensitivity reactions to cephalosporins. Expert Opin Drug Saf 2008;7:295-304 (Pubitemid 351802829)
12. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005;115:1048-57
13. Cunha BA. Antibiotic selection in the penicillin-allergic patient. Med Clin North Am 2006;90:1257-64 (Pubitemid 44751029)
14. Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs 2007;67:1027-52 (Pubitemid 46744477)
15. Park MA, Li JT. Diagnosis and management of penicillin allergy. Mayo Clin Proc 2005;80:405-10 (Pubitemid 40316303)
16. Schafer JA, Mateo N, Parlier GL, Rotschafer JC. Penicillin allergy skin testing: what do we do now? Pharmacotherapy 2007;27:542-5 (Pubitemid 46536235)
17. Wong BK, Sahly Y, Mistry G, et al. Comparative disposition of [14C] ertapenem, a novel carbapenem antibiotic, in rat, monkey and man. Xenobiotica 2004;34:379-89 (Pubitemid 38621716)
18. Harrison MP, Haworth SJ, Moss SR, et al. The disposition and metabolic fate of 14C-meropenem in man. Xenobiotica 1993;23:1311-23 (Pubitemid 23330759)
19. Frumin J, Gallagher JC. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances? Ann Pharmacother 2009;43:304-15
20. Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. Jama 2001;285:2498-505 (Pubitemid 32433844)
21. Jappe U. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation? Allergy 2007;62:1474-5 (Pubitemid 350045594)
22. Yates AB, deShazo RD. Allergic and nonallergic drug reactions. South Med J 2003;96:1080-7 (Pubitemid 38281641)
23. Clark BM, Kotti GH, Shah AD, Conger NG. Severe serum sickness reaction to oral and intramuscular penicillin. Pharmacotherapy 2006;26:705-8 (Pubitemid 43673054)
24. Pichler WJ. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004;24:373-97.v-vi (Pubitemid 38887344)
25. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract 1994;48:5-7
26. Ahlstedt S. Penicillin allergy-can the incidence be reduced? Allergy 1984;39:151-64
27. Sogn DD, Evans R III, Shepherd GM, et al. Results of the national institute of allergy and infectious diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992;152:1025-32
28. Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968;38:159-88
29. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001;345:804-9
30. Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med 2003;70:113-25 (Pubitemid 36322202)
31. Shariatmadar S, Storry JR, Sausais L, Reid ME. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery. Immunohematol 2004;20:63-6 (Pubitemid 38292749)
32. Kunzmann S, Thomas W, Mayer B, et al. Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis. Infection 2010;38:131-4
33. Kakaiya R, Cseri J, Smith S, et al. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry. Arch Pathol Lab Med 2004;128:905-7 (Pubitemid 39014126)
34. Barton LL. Cefuroxime-induced immune hemolysis. J Pediatr 2004;144:690; author reply
35. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009;(1):73-9
36. Arndt PA, Garratty G, Hill J, et al. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method. Vox Sang 2002;83:273-8 (Pubitemid 36807279)
37. Andres E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol 2008;15:15-21 (Pubitemid 350191024)
38. Kurokawa I. A case of purpuric drug eruption due to cefaclor. Int J Antimicrob Agents 2002;20:393-4 (Pubitemid 35300439)
39. Kaufman DW, Kelly JP, Johannes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714-18 (Pubitemid 23318077)
40. Abate G, Godbole K, Springston C. Piperacillin/tazobactam-induced petechial rash. Ann Pharmacother 2010;44:1345-6
41. King BA, Geelhoed GC. Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions. J Paediatr Child Health 2003;39:677-81
42. Yesudian PD, King CM. Occupational allergic contact dermatitis from meropenem. Contact Dermat 2001;45:53 (Pubitemid 32625320)
43. Kim YH, Ko JY, Kim YS, Ro YS. A case of allergic contact dermatitis to clavulanic acid. Contact Dermat 2008;59:378-9
44. Rosso R, Mattiacci G, Bernardi ML, et al. Very delayed reactions to beta-lactam antibiotics. Contact Dermat 2000;42:293-5 (Pubitemid 30219374)
45. Hausermann P, Bircher AJ. Immediate and delayed hypersensitivity to ceftriaxone, and anaphylaxis due to intradermal testing with other beta-lactam antibiotics, in a previously amoxicillin-sensitized patient. Contact Dermat 2002;47:311-12 (Pubitemid 36174245)
46. de Thier F, Blondeel A, Song M. Acute generalized exanthematous pustulosis induced by amoxycillin with clavulanate. Contact Dermat 2001;44:114-15 (Pubitemid 32055707)
47. Conde-Salazar L, Guimaraens D, Gonzalez MA, Mancebo E. Occupational allergic contact urticaria from amoxicillin. Contact Dermat 2001;45:109 (Pubitemid 32738432)
48. Andre MC, Silva R, Filipe PL, et al. Systemic contact allergy to penicillin after prick and intradermal tests. Ann Allergy Asthma Immunol 2011;106:174-5
49. Yawalkar N, Hari Y, Frutig K, et al. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 2000;115:647-52
50. Song EK, Seon JK, Jeong MS. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement. J Bone Joint Surg Br 2010;92:1596-9
51. Romano A, Torres MJ, Quaratino D, et al. Diagnostic evaluation of delayed hypersensitivity to systematically administered drugs. Allergy 1999;54(Suppl 58):23-7 (Pubitemid 30126703)
52. Romano A, Viola M, Gaeta F, et al. Patch testing in non-immediate drug eruptions. Allergy Asthma Clin Immunol 2008;4:66-74 (Pubitemid 351880900)
53. Narayanan VS, Mamatha GP, Ashok L, Rajashekar N. Steven Johnson syndrome due to I.V Ceftriaxone-a case report. Indian J Dent Res 2003;14:220-3
54. Thestrup-Pedersen K, Hainau B, Al'Eisa A, et al. Fatal toxic epidermal necrolysis associated with ceftazidine and vancomycin therapy: a report of two cases. Acta Derm Venereol 2000;80:316-17
55. Lopez S, Blanca-Lopez N, Cornejo-Garcia JA, et al. Nonimmediate reactions to betalactams. Curr Opin Allergy Clin Immunol 2007;7:310-16 (Pubitemid 47052018)
56. Lissia M, Mulas P, Bulla A, Rubino C. Toxic epidermal necrolysis (Lyell's disease). Burns 2010;36:152-63
57. Forman R, Koren G, Shear NH. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf 2002;25:965-72 (Pubitemid 35252720)
58. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011;22:411-18
59. Cacoub P, Musette P, Descamps V, et al. The dress syndrome: a literature review. Am J Med 2011;124:588-97
60. Dash CH. Penicillin allergy and the cephalosporins. J Antimicrob Chemother 1975;1:107-18
61. Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978;137(Suppl):S74-S9
62. Petz LD. Immunologic reactions of humans to cephalosporins. Postgrad Med J 1971;47(Suppl):64-9
63. Smith JW, Johnson JE, Cluff LE. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med 1966;274:998-1002
64. Baumgart KW, Baldo BA. Cephalosporin allergy. N Engl J Med 2002;346:380-1
65. Blanca M, Mayorga C, Torres MJ, et al. Side-chain-specific reactions to betalactams: 14 years later. Clin Exp Allergy 2002;32:192-7 (Pubitemid 34429596)
66. Miranda A, Blanca M, Vega JM, et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996;98:671-7 (Pubitemid 26377933)
67. Blanca M, Vega JM, Garcia JJ, et al. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Exp Allergy 1989;19:556-8 (Pubitemid 19237910)
68. Blanca M, Perez E, Garcia J, et al. Anaphylaxis to amoxycillin but good tolerance for benzyl penicillin. In vivo and in vitro studies of specific IgE antibodies. Allergy 1988;43:508-10
69. Blanca M, Fernandez J, Miranda A, et al. Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies. J Allergy Clin Immunol 1989;83:381-5 (Pubitemid 19079730)
70. Madaan A, Li JT. Cephalosporin allergy. Immunol Allergy Clin North Am 2004;24:463-76.vi-vii (Pubitemid 38887348)
71. Romano A, Viola M, Gueant-Rodriguez RM, et al. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007;146:266-9 (Pubitemid 351650612)
72. Romano A, Viola M, Gueant-Rodriguez RM, et al. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med 2006;354:2835-7 (Pubitemid 43974216)
73. Atanaskovic-Markovic M, Gaeta F, Medjo B, et al. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy 2008;63:237-40
74. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004;59:1153-60 (Pubitemid 39389467)
75. Fox S, Park MA. Penicillin skin testing in the evaluation and management of penicillin allergy. Ann Allergy Asthma Immunol 2011;106:1-7
76. Bousquet PJ, Gaeta F, Bousquet-Rouanet L, et al. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des 2008;14:2792-802
77. Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des 2008;14:2778-91
78. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009;64:183-93
79. Strom BL, Carson JL, Schinnar R, et al. Descriptive epidemiology of agranulocytosis. Arch Intern Med 1992;152:1475-80
80. Andres E, Maloisel F, Kurtz JE, et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med 2002;13:324-8 (Pubitemid 34812343)
81. Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007;146:657-65 (Pubitemid 351650522)
82. Scheetz MH, McKoy JM, Parada JP, et al. Systematic review of piperacillin-induced neutropenia. Drug Saf 2007;30:295-306 (Pubitemid 46624529)
83. Andres E, Zimmer J, Affenberger S, et al. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med 2006;17:529-35 (Pubitemid 44827712)
84. Claas FH. Immune mechanisms leading to drug-induced blood dyscrasias. Eur J Haematol Suppl 1996;60:64-8
85. Guest I, Uetrecht J. Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses 1999;53:145-51 (Pubitemid 29433645)
86. Kerr RO, Cardamone J, Dalmasso AP, Kaplan ME. Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N Engl J Med 1972;287:1322-5
87. Mayer B, Yurek S, Salama A. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature. Transfusion 2010;50:1135-8
88. Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390-4
89. Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf 2009;8:73-9
90. Gooding PG, Clark BJ, Sathe SS. Piperacillin: a review of clinical experience. J Antimicrob Chemother 1982;9(Suppl B):93-9 (Pubitemid 12159493)
91. Nieminen U, Kekomaki R. Quinidine-induced thrombocytopenic purpura: clinical presentation in relation to drug-dependent and drug-independent platelet antibodies. Br J Haematol 1992;80:77-82
92. Smith CR. Cefotaxime and cephalosporins: adverse reactions in perspective. Rev Infect Dis 1982;4(Suppl):S481-8
93. Young JP, Husson JM, Bruch K, et al. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. J Antimicrob Chemother 1980;6(Suppl A):293-300 (Pubitemid 11192461)
94. Schiffer CA, Weinstein HJ, Wiernik PH. Letter: methicillin-associated thrombocytopenia. Ann Intern Med 1976;85:338-9
95. Koklu S, Yuksel O, Filik L, et al. Recurrent cholestasis due to ampicillin. Ann Pharmacother 2003;37:395-7 (Pubitemid 36249642)
96. Ersoz G, Karasu Z, Yildiz C, et al. Severe toxic hepatitis associated with amoxycillin and clavulanic acid. J Clin Pharm Ther 2001;26:225-9 (Pubitemid 32592554)
97. Thomson JA, Fairley CK, Ugoni AM, et al. Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust 1995;162:638-40
98. Cundiff J, Joe S. Amoxicillin-clavulanic acid-induced hepatitis. Am J Otolaryngol 2007;28:28-30 (Pubitemid 44879655)
99. Smith LA, Ignacio JR, Winesett MP, et al. Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 2005;41:469-73 (Pubitemid 41407611)
100. Hargreaves JE, Herchline TE. Severe cholestatic jaundice caused by mezlocillin. Clin Infect Dis 1992;15:179-80
101. Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 1990;99:1772-8
102. Michielsen PP, Fierens H, Van Maercke YM. Drug-induced gallbladder disease. Incidence, aetiology and management. Drug Saf 1992;7:32-45
103. Calandra GB, Wang C, Aziz M, Brown KR. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients. J Antimicrob Chemother 1986;18(Suppl E):193-202 (Pubitemid 17212645)
104. Berger M, Potter DE. Pitfall in diagnosis of viral hepatitis on haemodialysis unit. Lancet 1977;2:95-6
105. Maraqa NF, Gomez MM, Rathore MH, Alvarez AM. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials. Clin Infect Dis 2002;34:50-4 (Pubitemid 33152665)
106. Graft DF, Chesney PJ. Use of ticarcillin following carbenicillin- associated hepatotoxicity. J Pediatr 1982;100:497-9 (Pubitemid 12180030)
107. Woodroffe AJ, Weldon M, Meadows R, Lawrence JR. Acute interstitial nephritis following ampicillin hypersensitivity. Med J Aust 1975;1:65-8
108. Lee HA, Hill LF. The use of ampicillin in renal disease. Br J Clin Pract 1968;22:354-7
109. Woodroffe AJ, Thomson NM, Meadows R, Lawrence JR. Nephropathy associated with methicillin administration. Aust N Z J Med 1974;4:256-61
110. Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med 1978;65:756-65 (Pubitemid 9098943)
111. Cogan MC, Arieff AI. Sodium wasting, acidosis and hyperkalemia induced by methicillin interstitial nephritis. Evidence for selective distal tubular dysfunction. Am J Med 1978;64:500-7 (Pubitemid 8302309)
112. Yow MD, Taber LH, Barrett FF, et al. A ten-year assessment of methicillin-associated side effects. Pediatrics 1976;58:329-34
113. Baldwin DS, Levine BB, McCluskey RT, Gallo GR. Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med 1968;279:1245-52
114. Flax MH. Editorial: drug-induced autoimmunity. N Engl J Med 1974;291:414-15
115. Sanjad SA, Haddad GG, Nassar VH. Nephropathy, an underestimated complication of methicillin therapy. J Pediatr 1974;84:873-7
116. Neu HC. Antistaphylococcal penicillins. Med Clin North Am 1982;66:51-60 (Pubitemid 12154253)
117. Serdaru M, Diquet B, Lhermitte F. Generalized seizures and ampicillin. Lancet 1982;2:617-18
118. Schmitt BD, Krivit W. Benign intracranial hypertension associated with a delayed penicillin reaction. Pediatrics 1969;43:50-3
119. Kallay MC, Tabechian H, Riley GR, Chessin LN. Neurotoxicity due to ticarcillin in patient with renal failure. Lancet 1979;1:608-9 (Pubitemid 9136401)
120. Malanga CJ, Kokontis L, Mauzy S. Piperacillin-induced seizures. Clin Pediatr (Phila) 1997;36:475-8 (Pubitemid 27344155)
121. Erikssen J, Midtvedt T, Bergan T. Treatment of urinary tract infections with cephalexin. Scand J Infect Dis 1970;2:53-8
122. Saker BM, Musk AW, Haywood EF, Hurst PE. Reversible toxic psychosis after cephalexin. Med J Aust 1973;1:497-8
123. Feder HM Jr. Comparative tolerability of ampicillin, amoxicillin, and trimethoprim-sulfamethoxazole suspensions in children with otitis media. Antimicrob Agents Chemother 1982;21:426-7 (Pubitemid 12117788)
124. Gurwith MJ, Rabin HR, Love K. Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis 1977;135(Suppl):S104-10
125. Knudsen ET. Amoxil and Talpen. Br Med J 1977;1:903
126. White AR, Kaye C, Poupard J, et al. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 2004;53(Suppl 1):i3-20
127. Bush LM, Johnson CC. Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations. Infect Dis Clin North Am 2000;14:409-33.ix
128. Neu HC, Wilson AP, Gruneberg RN. Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. J Chemother 1993;5:67-93 (Pubitemid 23174123)
129. Scott LJ, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 2001;61:1455-500 (Pubitemid 32783748)
130. de Vries-Hospers HG, Tonk RH, van der Waaij D. Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers. Scand J Infect Dis 1991;23:625-33
131. Mitropoulos IF, Rotschafer JC, Rodvold KA. Adverse events associated with the use of oral cephalosporins/cephems. Diagn Microbiol Infect Dis 2007;57:67S-76S
132. Bow EJ, Rotstein C, Noskin GA, et al. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin- tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis 2006;43:447-59 (Pubitemid 44157153)
133. Kuye O, Teal J, DeVries VG, et al. Safety profile of piperacillin/ tazobactam in phase I and III clinical studies. J Antimicrob Chemother 1993;31(Suppl A):113-24 (Pubitemid 23078103)
134. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005;18:247-63 (Pubitemid 40548293)
135. Knoop FC, Owens M, Crocker IC. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 1993;6:251-65 (Pubitemid 23231208)
136. Yam FK, Smith KM. "Collateral damage": antibiotics and the risk of Clostridium difficile infection. Orthopedics 2005;28:275-9 (Pubitemid 40425855)
137. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9 (Pubitemid 41770165)
138. Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004;38:646-8 (Pubitemid 38333859)
139. Isaacs D. Serum sickness-like reaction to cefaclor. J Paediatr Child Health 2001;37:298-9 (Pubitemid 32619849)
140. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study. Pediatr Infect Dis 1985;4:358-61 (Pubitemid 15027304)
141. Kearns GL, Wheeler JG, Childress SH, Letzig LG. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr 1994;125:805-11 (Pubitemid 24350196)
142. Boyd IW. Cefaclor-associated serum sickness. Med J Aust 1998;169:443-4
143. Neu HC. Third generation cephalosporins: safety profiles after 10 years of clinical use. J Clin Pharmacol 1990;30:396-403 (Pubitemid 20228340)
144. Ozturk A, Kaya M, Zeyrek D, et al. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children. Acta Radiol 2005;46:112-16 (Pubitemid 41673298)
145. de Moor RA, Egberts AC, Schroder CH. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis. Eur J Pediatr 1999;158:975-7
146. Bickford CL, Spencer AP. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Pharmacotherapy 2005;25:1389-95 (Pubitemid 41407637)
147. Steadman E, Raisch DW, Bennett CL, et al. Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother 2010;54:1534-40
148. Qiao HL, Liu JH, Yang J, Dong ZM. Relationships between skin test, specific IgE and levels of cytokines in patients with penicillin allergy. Int J Clin Pract 2005;59:895-9
149. Fontaine C, Mayorga C, Bousquet PJ, et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 2007;62:47-52 (Pubitemid 44902734)
150. Rosario NA, Grumach AS. Allergy to beta-lactams in pediatrics: a practical approach. J Pediatr (Rio J) 2006;82:S181-8 (Pubitemid 44974671)
151. Bryson EO, Frost EA, Rosenblatt MA. Management of the patient reporting an allergy to penicillin. Middle East J Anesthesiol 2007;19:495-512
152. Bougie DW, Wilker PW, Birenbaum JA. Drug-dependent antibody. What binds where. J Thromb Haemost 2003;1:abstract OC023